Skip to main content
. 2021 Apr 1;11:7355. doi: 10.1038/s41598-021-86785-z

Figure 3.

Figure 3

Comparison of BCR-free survival of the prostate cancer patients with exosomal miR-26a-5p (A), miR-532-5p (B), and miR-99b-3p (C). Patients with high miRNA expression showed significantly shorter BCR-free survival than those with low miRNA expression.